Nova Eye Medical Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €31.95M +23.9% €4.07M +235.0% 12.7% +0.080 pp €3.90M +335.6% 12.2% +0.087 pp
    (estimated) €25.78M +25.8% €1.22M -189.3% 4.7% +0.11 pp €896.26K -160.8% 3.5% +0.11 pp
    (estimated) €20.50M +22.4% -€1.36M -67.2% -6.6% +0.18 pp -€1.47M -20.3% -7.2% +0.039 pp
    (estimated) €16.75M +28.2% -€4.15M -15.8% -24.7% +0.13 pp -€1.85M -55.5% -11.0% +0.21 pp
    €13.07M +37.0% -€4.92M -42.5% -37.7% +0.52 pp -€4.15M +25.1% -31.8% +0.030 pp
    €9.54M +27.3% -€8.57M +104.0% -89.8% -0.34 pp -€3.32M -752.1% -34.8% -0.42 pp
    €7.49M -0.1% -€4.20M +72.1% -56.0% -0.24 pp €508.63K -108.5% 6.8% +0.87 pp
    €7.50M +4.9% -€2.44M -37.7% -32.5% +0.22 pp -€5.98M -250.1% -79.7% -1.4 pp
    €7.15M -20.9% -€3.92M +5.0% -54.7% -0.13 pp €3.98M -304.4% 55.7% +0.77 pp
    €9.04M -79.7% -€3.73M +31.3% -41.3% -0.35 pp -€1.95M -209.9% -21.6% -0.26 pp
    €44.49M +10.6% -€2.84M +467.6% -6.4% -0.051 pp €1.77M -11.1% 4.0% -0.0098 pp
    €40.22M -1.7% -€500.78K -129.5% -1.2% -0.054 pp €2.00M -65.5% 5.0% -0.092 pp
    €40.90M +16.3% €1.70M +80.2% 4.1% +0.015 pp €5.79M +23.4% 14.2% +0.0081 pp
    €35.16M +15.4% €941.07K +113.2% 2.7% +0.012 pp €4.69M +125.1% 13.3% +0.065 pp
    €30.46M +26.2% €441.41K -196.6% 1.4% +0.033 pp €2.08M +46.0% 6.8% +0.0093 pp
    €24.13M -9.3% -€457.09K -188.7% -1.9% -0.038 pp €1.43M -25.8% 5.9% -0.013 pp
    €26.61M +10.2% €515.35K -229.6% 1.9% +0.036 pp €1.92M +57.4% 7.2% +0.022 pp
    €24.15M -11.2% -€397.71K -118.6% -1.6% -0.095 pp €1.22M -65.8% 5.1% -0.081 pp
    €27.20M -18.1% €2.14M -116.9% 7.9% +0.46 pp €3.58M -10.0% 13.2% +0.012 pp
    €33.19M +15.8% -€12.67M -576.6% -38.2% -0.47 pp €3.98M +215.1% 12.0% +0.076 pp
    €28.67M +12.5% €2.66M +11.2% 9.3% -0.0011 pp €1.26M -45.8% 4.4% -0.047 pp
    €25.49M +31.2% €2.39M +15.5% 9.4% -0.013 pp €2.33M +33.6% 9.1% +0.0017 pp
    €19.43M +28.8% €2.07M -435.1% 10.6% +0.15 pp €1.74M -223.1% 9.0% +0.18 pp
    €15.09M +9.2% -€617.30K +435.0% -4.1% -0.033 pp -€1.42M -203.0% -9.4% -0.19 pp
    €13.82M -5.0% -€115.39K -112.6% -0.8% -0.071 pp €1.38M -23.6% 10.0% -0.024 pp
    €14.54M -5.1% €914.18K -1,083.1% 6.3% +0.069 pp €1.80M +58.1% 12.4% +0.050 pp
    €15.32M +17,096,150.0% -€92.99K -64.1% -0.6% +2.9K pp €1.14M -541.7% 7.4% +2.9K pp
    €89.63 +∞% -€258.79K +25.5% -288,750.0% -2.9K pp -€257.67K -46,099.6% -287,497.5% -2.9K pp
    €0.00 +NaN% -€206.14K -49.5% N/A €560.16 -75.0% N/A
    €0.00 +NaN% -€407.80K +8.7% N/A €2.24K -95.8% N/A
    €0.00 -100.0% -€375.31K +149.1% N/A €53.78K -141.2% N/A
    €57.14K +1,253.9% -€150.68K +95.2% -263.7% +16 pp -€130.39K +4.4% -228.2% +27 pp
    €4.22K +7.6% -€77.18K -210.2% -1,828.8% -36 pp -€124.95K +168.7% -2,960.7% -18 pp
    €3.92K -94.0% €70.02K -160.7% 1,785.7% +20 pp -€46.49K -32.0% -1,185.7% -11 pp
    €65.54K +48.1% -€115.39K -54.0% -176.1% +3.9 pp -€68.34K -59.1% -104.3% +2.7 pp
    €44.25K -55.6% -€250.95K -16.3% -567.1% -2.7 pp -€166.93K -24.6% -377.2% -1.6 pp
    €99.71K -47.2% -€299.69K +65.6% -300.6% -2.0 pp -€221.26K -∞% -221.9% -2.2 pp
    €188.77K -52.4% -€180.93K -88.2% -95.8% +2.9 pp €0.00 +NaN% 0.0% +0.0 pp
    €396.59K -37.5% -€1.54M -79.3% -387.1% +7.8 pp €0.00 +NaN% 0.0% +0.0 pp
    €634.66K -€7.42M -1,168.5% €0.00 0.0%

    Notifications